Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed M Elshazly

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Autophagy|May 4, 2026
Turning adaptive resistance into vulnerability: AUTAC-Mediated degradation of Mcl1Ahmed M Elshazly, Senthil K Radhakrishnan
International Journal of Molecular Sciences|August 26, 2023
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET InhibitorsAhmed M Elshazly, David A Gewirtz
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancerAhmed M Elshazly, David A Gewirtz
Cells|February 25, 2023
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?Ahmed M Elshazly, David A Gewirtz
International Journal of Molecular Sciences|October 14, 2023
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted TherapiesAhmed M Elshazly, David A Gewirtz
Cancers|October 28, 2023
Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate CancerAhmed M Elshazly, David A Gewirtz
Biomedicines|July 27, 2022
The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells-Implications for Autophagy Modulation as a Therapeutic StrategyJingwen Xu, Ahmed M Elshazly, David A Gewirtz
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodiesAhmed M Elshazly, Aya A Elzahed, David A Gewirtz
Toxicology and Applied Pharmacology|March 20, 2024
Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathwaySherin Zakaria, Ahmed M Elshazly, Reem Alaa, et al.
Frontiers in Bioscience (Landmark Edition)|June 28, 2024
The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR InhibitorsAhmed M Elshazly, Aya A Elzahed, David A Gewirtz
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Autophagy|May 4, 2026
Turning adaptive resistance into vulnerability: AUTAC-Mediated degradation of Mcl1Ahmed M Elshazly, Senthil K Radhakrishnan
International Journal of Molecular Sciences|August 26, 2023
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET InhibitorsAhmed M Elshazly, David A Gewirtz
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancerAhmed M Elshazly, David A Gewirtz
Cells|February 25, 2023
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?Ahmed M Elshazly, David A Gewirtz
International Journal of Molecular Sciences|October 14, 2023
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted TherapiesAhmed M Elshazly, David A Gewirtz
Cancers|October 28, 2023
Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate CancerAhmed M Elshazly, David A Gewirtz
Biomedicines|July 27, 2022
The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells-Implications for Autophagy Modulation as a Therapeutic StrategyJingwen Xu, Ahmed M Elshazly, David A Gewirtz
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodiesAhmed M Elshazly, Aya A Elzahed, David A Gewirtz
Toxicology and Applied Pharmacology|March 20, 2024
Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathwaySherin Zakaria, Ahmed M Elshazly, Reem Alaa, et al.
Frontiers in Bioscience (Landmark Edition)|June 28, 2024
The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR InhibitorsAhmed M Elshazly, Aya A Elzahed, David A Gewirtz
Pageof 4